Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 2 |
2008 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
The molecular classification of multiple myeloma.
Blood. 2006 Sep 15;108(6):2020-8. doi: 10.1182/blood-2005-11-013458. Epub 2006 May 25.
Blood. 2006.
PMID: 16728703
Free PMC article.
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.
Zhan F, Colla S, Wu X, Chen B, Stewart JP, Kuehl WM, Barlogie B, Shaughnessy JD Jr.
Zhan F, et al.
Blood. 2007 Jun 1;109(11):4995-5001. doi: 10.1182/blood-2006-07-038703. Epub 2007 Feb 15.
Blood. 2007.
PMID: 17303695
Free PMC article.
Item in Clipboard
Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway.
Knobloch J, Shaughnessy JD Jr, Rüther U.
Knobloch J, et al.
FASEB J. 2007 May;21(7):1410-21. doi: 10.1096/fj.06-7603com. Epub 2007 Feb 5.
FASEB J. 2007.
PMID: 17283219
Item in Clipboard
Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myeloma.
Tian E, Landowski TH, Stephens OW, Yaccoby S, Barlogie B, Shaughnessy JD Jr.
Tian E, et al.
Mol Cancer Ther. 2008 Mar;7(3):500-9. doi: 10.1158/1535-7163.MCT-07-0524. Epub 2008 Mar 4.
Mol Cancer Ther. 2008.
PMID: 18319333
Item in Clipboard
Cite
Cite